Gaurav Aggarwal serves as Executive at HYPERION THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Gaurav Aggarwal has executed 10 insider transactions totaling $21.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 25, 2025 involved exercising options for 652,900 shares valued at $0.
Gaurav Aggarwal currently holds 1,789,915 shares of HYPERION THERAPEUTICS INC (HPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gaurav Aggarwal has been a net buyer of HPTX stock. They have purchased $21.7M and sold $0 worth of shares.
Gaurav Aggarwal's most recent insider trade was on Aug 25, 2025, when they sold 652,900 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 11, 2023 | UNCY | $0 | Conversion | 3,470,152 | $N/A | Discretionary |
| Jul 1, 2022 | SRRA | $150.5M | Disposition | 2,735,853 | $55.00 | Discretionary |
| Jan 31, 2022 | SRRA | $21.6M | Purchase | 800,000 | $27.00 | Discretionary |
| Jan 26, 2022 | SRRA | $6.3M | Exercise | 480,277 | $13.20 | Discretionary |
| Jan 29, 2020 | SRRA | $0 | Conversion | 1,455,576 | $N/A | Discretionary |
| Jan 15, 2016 | OCRX | $21.5K | Purchase | 10,000 | $2.15 | Discretionary |
| May 6, 2015 | OCRX | $27.1K | Purchase | 7,500 | $3.62 | Discretionary |
| Jul 31, 2012 | HPTX | $50.0K | Purchase | 5,000 | $10.00 | Discretionary |